News > News Archive
Novartis Stalevo FIRST STEP Study Publication Press Release
Patients with early Parkinson’s disease experienced better symptom control and improvements in daily activities with Stalevo® than carbidopa/levodopa, according to newly-published study.
Click for a printer friendly version
Return to News Archive
